Form Type: 4

SEC EDGAR Link
Acccession Number:0001437749-19-018247
Date:2019-09-09
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
Original Submission Date:

Reporting Person:

RICE MICHAEL
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL, WA 98021

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-09-09 M 14,000 a $1.12 189,014 direct
COMMON STOCK 2019-09-09 S 14,000 d $19.43 175,014 direct
COMMON STOCK 2019-09-11 M 14,571 a $1.12 189,585 direct
COMMON STOCK 2019-09-11 S 14,571 d $19.36 175,014 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION 1.121 2019-09-09 deemed execution date M 14,000 (d) 2021-02-25 common stock 14,000 $1.12 14,571 direct
EMPLOYEE STOCK OPTION 1.121 2019-09-11 deemed execution date M 14,571 (d) 2021-02-25 common stock 14,571 $1.12 0 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 17, 2019.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $19.33 to $19.56, inclusive. the reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $19.30 to $19.41, inclusive. the reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range.
f4 option vested as of the last day of the calendar quarter in which the company first achieved cash flow break even after the grant date.

Elevate your investments